Skip to main content
Erschienen in: Osteoporosis International 2/2016

01.02.2016 | Original Article

A 2-year prospective densitometric study on the influence of Fok-I gene polymorphism in young patients with thalassaemia major

verfasst von: M. Dimitriadou, A. Christoforidis, L. Fidani, M. Economou, E. Vlachaki, M. Athanassiou-Metaxa, G. Katzos

Erschienen in: Osteoporosis International | Ausgabe 2/2016

Einloggen, um Zugang zu erhalten

Abstract

Summary

This study is to estimate the degree of genetic contribution of Fok-I gene polymorphism of Vitamin D receptor to bone mass in patients with thalassaemia. Results indicate a protective role of the f allele of the Fok-I gene polymorphism when found in homozygosity on bone mineral density of young thalassemic patients.

Introduction

The purpose of this study is to estimate prospectively the degree of genetic contribution of Fok-I gene polymorphism of vitamin D receptor (VDR) to the evolution of bone mass in patients with beta-thalassemia major (b-TH).

Methods

Sixty-four children and young adults (33 males and 31 females) with mean decimal age of 23.20 ± 5.41 (range 9.25–32.41 years) were recruited in this study. All patients were genotyping for Fok-I gene polymorphism and were assessed with dual energy X-ray absorptiometry (DXA) at baseline and 2 years after. Z-scores were calculated based on normal age and sex matched Caucasian population. Metabolites of vitamin D, intact PTH, total calcium, inorganic phosphorous, and alkaline phosphatase were measured at the serum pre-transfusion.

Results

A moderate proportion of patients had decreased DXA Z-scores (Z-score ≤−2) predominately in total hip (31 %) and secondary in lumbar spine (15.6 %). Patients being homozygous for the f allele had apparently higher BMD Z-scores compared with those carrying the F allele in homo- or heterozygosity, however, with a difference that did not reached significance. Interestingly enough, a significant deterioration in BMD Z-scores measured at femur (FF: P = 0.004 Ff: P < 0.001, ff: P = 0.024) and total hip (FF: P = 0.022, Ff: P = 0.005) was recorded for all type of genotypes, except for ff genotype and with regard to the total hip DXA values. An increased prevalence of serum 25(OH)D3 deficiency (59.4 %) and 25(OH)D3 borderline (12.5 %) was recorded.

Conclusion

Our study indicates a protective role of the f allele of the Fok-I gene polymorphism when found in homozygosity on bone mineral density of young patients with b-TM.
Literatur
1.
Zurück zum Zitat Ladis V, Karagiorga-Lagana M, Tsatra I, Chouliaras G (2013) Thirty-year experience in preventing haemoglobinopathies in Greece: achievements and potentials for optimisation. Eur J Haematol 90(4):313–322. doi:10.1111/ejh.12076 CrossRefPubMed Ladis V, Karagiorga-Lagana M, Tsatra I, Chouliaras G (2013) Thirty-year experience in preventing haemoglobinopathies in Greece: achievements and potentials for optimisation. Eur J Haematol 90(4):313–322. doi:10.​1111/​ejh.​12076 CrossRefPubMed
2.
Zurück zum Zitat Skordis N, Toumba M (2011) Bone disease in thalassaemia major: recent advances in pathogenesis and clinical aspects. Pediatr Endocrinol Rev 8(Suppl 2):300–306PubMed Skordis N, Toumba M (2011) Bone disease in thalassaemia major: recent advances in pathogenesis and clinical aspects. Pediatr Endocrinol Rev 8(Suppl 2):300–306PubMed
4.
Zurück zum Zitat Voskaridou E, Terpos E (2008) Pathogenesis and management of osteoporosis in thalassemia. Pediatr Endocrinol Rev 6(Suppl 1):86–93PubMed Voskaridou E, Terpos E (2008) Pathogenesis and management of osteoporosis in thalassemia. Pediatr Endocrinol Rev 6(Suppl 1):86–93PubMed
6.
Zurück zum Zitat Lucotte G, Mercier G, Burckel A (1999) Fok I polymorphism at the human vitamin D receptor gene locus in Europeans and Africans. Clin Genet 55(4):281–282CrossRefPubMed Lucotte G, Mercier G, Burckel A (1999) Fok I polymorphism at the human vitamin D receptor gene locus in Europeans and Africans. Clin Genet 55(4):281–282CrossRefPubMed
7.
Zurück zum Zitat Kalkwarf HJ, Zemel BS, Gilsanz V, Lappe JM, Horlick M, Oberfield S, Mahboubi S, Fan B, Frederick MM, Winer K, Shepherd JA (2007) The bone mineral density in childhood study: bone mineral content and density according to age, sex, and race. J Clin Endocrinol Metab 92(6):2087–2099. doi:10.1210/jc.2006-2553 CrossRefPubMed Kalkwarf HJ, Zemel BS, Gilsanz V, Lappe JM, Horlick M, Oberfield S, Mahboubi S, Fan B, Frederick MM, Winer K, Shepherd JA (2007) The bone mineral density in childhood study: bone mineral content and density according to age, sex, and race. J Clin Endocrinol Metab 92(6):2087–2099. doi:10.​1210/​jc.​2006-2553 CrossRefPubMed
8.
Zurück zum Zitat Chiotis DT G, Hatzisymeon M, Maniati-Christidi M, Dacou-Voutetakis D (2003) Height and weight of children of Hellenic origin aged 0–18 years (2000–2001): comparison with data collected during the period 1978–1979. Ann Clin Pediatr Univ Atheniensis 50(2):136–155 Chiotis DT G, Hatzisymeon M, Maniati-Christidi M, Dacou-Voutetakis D (2003) Height and weight of children of Hellenic origin aged 0–18 years (2000–2001): comparison with data collected during the period 1978–1979. Ann Clin Pediatr Univ Atheniensis 50(2):136–155
9.
Zurück zum Zitat Chiotis DK,X, Tsiftis G, Hatzisymeon M, Maniati-Christidi M, Dacou-Voutetaki A (2004) Body mass index and prevalence of obesity in subjects of Hellenic origin aged 0–18 years, living in the Athens area. Ann Clin Pediatr Unive Atheniensis 51(2):139–154 Chiotis DK,X, Tsiftis G, Hatzisymeon M, Maniati-Christidi M, Dacou-Voutetaki A (2004) Body mass index and prevalence of obesity in subjects of Hellenic origin aged 0–18 years, living in the Athens area. Ann Clin Pediatr Unive Atheniensis 51(2):139–154
12.
Zurück zum Zitat Jensen CE, Tuck SM, Agnew JE, Koneru S, Morris RW, Yardumian A, Prescott E, Hoffbrand AV, Wonke B (1998) High incidence of osteoporosis in thalassaemia major. J Pediatr Endocrinol Metab 11(Suppl 3):975–977PubMed Jensen CE, Tuck SM, Agnew JE, Koneru S, Morris RW, Yardumian A, Prescott E, Hoffbrand AV, Wonke B (1998) High incidence of osteoporosis in thalassaemia major. J Pediatr Endocrinol Metab 11(Suppl 3):975–977PubMed
14.
Zurück zum Zitat Singh K, Kumar R, Shukla A, Phadke SR, Agarwal S (2012) Status of 25-hydroxyvitamin D deficiency and effect of vitamin D receptor gene polymorphisms on bone mineral density in thalassemia patients of North India. Hematology 17(5):291–296. doi:10.1179/1607845412Y.0000000017 CrossRefPubMed Singh K, Kumar R, Shukla A, Phadke SR, Agarwal S (2012) Status of 25-hydroxyvitamin D deficiency and effect of vitamin D receptor gene polymorphisms on bone mineral density in thalassemia patients of North India. Hematology 17(5):291–296. doi:10.​1179/​1607845412Y.​0000000017 CrossRefPubMed
15.
Zurück zum Zitat Tantawy AA, El Kholy M, Moustafa T, Elsedfy HH (2008) Bone mineral density and calcium metabolism in adolescents with beta-thalassemia major. Pediatr Endocrinol Rev 6(Suppl 1):132–135PubMed Tantawy AA, El Kholy M, Moustafa T, Elsedfy HH (2008) Bone mineral density and calcium metabolism in adolescents with beta-thalassemia major. Pediatr Endocrinol Rev 6(Suppl 1):132–135PubMed
18.
Zurück zum Zitat Jakubowska-Pietkiewicz E, Mlynarski W, Klich I, Fendler W, Chlebna-Sokol D (2012) Vitamin D receptor gene variability as a factor influencing bone mineral density in pediatric patients. Mol Biol Rep 39(5):6243–6250. doi:10.1007/s11033-012-1444-z CrossRefPubMed Jakubowska-Pietkiewicz E, Mlynarski W, Klich I, Fendler W, Chlebna-Sokol D (2012) Vitamin D receptor gene variability as a factor influencing bone mineral density in pediatric patients. Mol Biol Rep 39(5):6243–6250. doi:10.​1007/​s11033-012-1444-z CrossRefPubMed
19.
Zurück zum Zitat Terpstra L, Knol DL, Van Coeverden SC, Delemarre-van de Waal HA (2006) Bone metabolism markers predict increase in bone mass, height and sitting height during puberty depending on the VDR Fok1 genotype. Clin Endocrinol (Oxf) 64(6):625–631. doi:10.1111/j.1365-2265.2006.02516.x CrossRef Terpstra L, Knol DL, Van Coeverden SC, Delemarre-van de Waal HA (2006) Bone metabolism markers predict increase in bone mass, height and sitting height during puberty depending on the VDR Fok1 genotype. Clin Endocrinol (Oxf) 64(6):625–631. doi:10.​1111/​j.​1365-2265.​2006.​02516.​x CrossRef
21.
Zurück zum Zitat Falchetti A, Sferrazza C, Cepollaro C, Gozzini A, Del Monte F, Masi L, Napoli N, Di Fede G, Cannone V, Cusumano G, Pandolfo MC, Rini GB, Tanini A, Brandi ML (2007) FokI polymorphism of the vitamin D receptor gene correlates with parameters of bone mass and turnover in a female population of the Italian island of Lampedusa. Calcif Tissue Int 80(1):15–20. doi:10.1007/s00223-005-0295-1 CrossRefPubMed Falchetti A, Sferrazza C, Cepollaro C, Gozzini A, Del Monte F, Masi L, Napoli N, Di Fede G, Cannone V, Cusumano G, Pandolfo MC, Rini GB, Tanini A, Brandi ML (2007) FokI polymorphism of the vitamin D receptor gene correlates with parameters of bone mass and turnover in a female population of the Italian island of Lampedusa. Calcif Tissue Int 80(1):15–20. doi:10.​1007/​s00223-005-0295-1 CrossRefPubMed
23.
Zurück zum Zitat Strandberg S, Nordstrom P, Lorentzon R, Lorentzon M (2003) Vitamin D receptor start codon polymorphism (FokI) is related to bone mineral density in healthy adolescent boys. J Bone Miner Metab 21(2):109–113. doi:10.1007/s007740300018 CrossRefPubMed Strandberg S, Nordstrom P, Lorentzon R, Lorentzon M (2003) Vitamin D receptor start codon polymorphism (FokI) is related to bone mineral density in healthy adolescent boys. J Bone Miner Metab 21(2):109–113. doi:10.​1007/​s007740300018 CrossRefPubMed
24.
Zurück zum Zitat Zajickova K, Zofkova I, Bahbouh R, Krepelova A (2002) Vitamin D receptor gene polymorphisms, bone mineral density and bone turnover: FokI genotype is related to postmenopausal bone mass. Physiol Res 51(5):501–509PubMed Zajickova K, Zofkova I, Bahbouh R, Krepelova A (2002) Vitamin D receptor gene polymorphisms, bone mineral density and bone turnover: FokI genotype is related to postmenopausal bone mass. Physiol Res 51(5):501–509PubMed
26.
Zurück zum Zitat Abrams SA, Griffin IJ, Hawthorne KM, Chen Z, Gunn SK, Wilde M, Darlington G, Shypailo RJ, Ellis KJ (2005) Vitamin D receptor Fok1 polymorphisms affect calcium absorption, kinetics, and bone mineralization rates during puberty. J Bone Miner Res 20(6):945–953. doi:10.1359/JBMR.050114 CrossRefPubMed Abrams SA, Griffin IJ, Hawthorne KM, Chen Z, Gunn SK, Wilde M, Darlington G, Shypailo RJ, Ellis KJ (2005) Vitamin D receptor Fok1 polymorphisms affect calcium absorption, kinetics, and bone mineralization rates during puberty. J Bone Miner Res 20(6):945–953. doi:10.​1359/​JBMR.​050114 CrossRefPubMed
27.
Zurück zum Zitat Arai H, Miyamoto K, Taketani Y, Yamamoto H, Iemori Y, Morita K, Tonai T, Nishisho T, Mori S, Takeda E (1997) A vitamin D receptor gene polymorphism in the translation initiation codon: effect on protein activity and relation to bone mineral density in Japanese women. J Bone Miner Res 12(6):915–921. doi:10.1359/jbmr.1997.12.6.915 CrossRefPubMed Arai H, Miyamoto K, Taketani Y, Yamamoto H, Iemori Y, Morita K, Tonai T, Nishisho T, Mori S, Takeda E (1997) A vitamin D receptor gene polymorphism in the translation initiation codon: effect on protein activity and relation to bone mineral density in Japanese women. J Bone Miner Res 12(6):915–921. doi:10.​1359/​jbmr.​1997.​12.​6.​915 CrossRefPubMed
30.
Zurück zum Zitat Christoforidis A, Kazantzidou E, Tsatra I, Tsantali H, Koliakos G, Hatzipantelis E, Katzos G, Athanassiou-Metaxa M (2007) Normal lumbar bone mineral density in optimally treated children and young adolescents with beta-thalassaemia major. Hormones (Athens) 6(4):334–340CrossRef Christoforidis A, Kazantzidou E, Tsatra I, Tsantali H, Koliakos G, Hatzipantelis E, Katzos G, Athanassiou-Metaxa M (2007) Normal lumbar bone mineral density in optimally treated children and young adolescents with beta-thalassaemia major. Hormones (Athens) 6(4):334–340CrossRef
31.
Zurück zum Zitat Wong P, Fuller PJ, Gillespie MT, Kartsogiannis V, Kerr PG, Doery JC, Paul E, Bowden DK, Strauss BJ, Milat F (2014) Thalassemia bone disease: a 19-year longitudinal analysis. J Bone Miner Res 29(11):2468–2473. doi:10.1002/jbmr.2266 CrossRefPubMed Wong P, Fuller PJ, Gillespie MT, Kartsogiannis V, Kerr PG, Doery JC, Paul E, Bowden DK, Strauss BJ, Milat F (2014) Thalassemia bone disease: a 19-year longitudinal analysis. J Bone Miner Res 29(11):2468–2473. doi:10.​1002/​jbmr.​2266 CrossRefPubMed
32.
Zurück zum Zitat Lasco A, Morabito N, Gaudio A, Crisafulli A, Meo A, Denuzzo G, Frisina N (2002) Osteoporosis and beta-thalassemia major: role of the IGF-I/IGFBP-III axis. J Endocrinol Invest 25(4):338–344. doi:10.1007/BF03344015 CrossRefPubMed Lasco A, Morabito N, Gaudio A, Crisafulli A, Meo A, Denuzzo G, Frisina N (2002) Osteoporosis and beta-thalassemia major: role of the IGF-I/IGFBP-III axis. J Endocrinol Invest 25(4):338–344. doi:10.​1007/​BF03344015 CrossRefPubMed
34.
Zurück zum Zitat Baldini M, Forti S, Marcon A, Ulivieri FM, Orsatti A, Tampieri B, Airaghi L, Zanaboni L, Cappellini MD (2010) Endocrine and bone disease in appropriately treated adult patients with beta-thalassemia major. Ann Hematol 89(12):1207–1213. doi:10.1007/s00277-010-1007-0 CrossRefPubMed Baldini M, Forti S, Marcon A, Ulivieri FM, Orsatti A, Tampieri B, Airaghi L, Zanaboni L, Cappellini MD (2010) Endocrine and bone disease in appropriately treated adult patients with beta-thalassemia major. Ann Hematol 89(12):1207–1213. doi:10.​1007/​s00277-010-1007-0 CrossRefPubMed
36.
Zurück zum Zitat Moulas A, Challa A, Chaliasos N, Lapatsanis PD (1997) Vitamin D metabolites (25-hydroxyvitamin D, 24,25-dihydroxyvitamin D and 1,25-dihydroxyvitamin D) and osteocalcin in beta-thalassaemia. Acta Paediatr 86(6):594–599CrossRefPubMed Moulas A, Challa A, Chaliasos N, Lapatsanis PD (1997) Vitamin D metabolites (25-hydroxyvitamin D, 24,25-dihydroxyvitamin D and 1,25-dihydroxyvitamin D) and osteocalcin in beta-thalassaemia. Acta Paediatr 86(6):594–599CrossRefPubMed
40.
Zurück zum Zitat Frisk P, Arvidson J, Ljunggren O, Gustafsson J (2012) Decreased bone mineral density in young adults treated with SCT in childhood: the role of 25-hydroxyvitamin D. Bone Marrow Transplant 47(5):657–662. doi:10.1038/bmt.2011.147 CrossRefPubMed Frisk P, Arvidson J, Ljunggren O, Gustafsson J (2012) Decreased bone mineral density in young adults treated with SCT in childhood: the role of 25-hydroxyvitamin D. Bone Marrow Transplant 47(5):657–662. doi:10.​1038/​bmt.​2011.​147 CrossRefPubMed
41.
Zurück zum Zitat Nakamura K, Ueno K, Nishiwaki T, Okuda Y, Saito T, Tsuchiya Y, Yamamoto M (2005) Nutrition, mild hyperparathyroidism, and bone mineral density in young Japanese women. Am J Clin Nutr 82(5):1127–1133, doi:82/5/1127 [pii]PubMed Nakamura K, Ueno K, Nishiwaki T, Okuda Y, Saito T, Tsuchiya Y, Yamamoto M (2005) Nutrition, mild hyperparathyroidism, and bone mineral density in young Japanese women. Am J Clin Nutr 82(5):1127–1133, doi:82/5/1127 [pii]PubMed
42.
Zurück zum Zitat Angelopoulos NG, Goula A, Rombopoulos G, Kaltzidou V, Katounda E, Kaltsas D, Tolis G (2006) Hypoparathyroidism in transfusion-dependent patients with beta-thalassemia. J Bone Miner Metab 24(2):138–145. doi:10.1007/s00774-005-0660-1 CrossRefPubMed Angelopoulos NG, Goula A, Rombopoulos G, Kaltzidou V, Katounda E, Kaltsas D, Tolis G (2006) Hypoparathyroidism in transfusion-dependent patients with beta-thalassemia. J Bone Miner Metab 24(2):138–145. doi:10.​1007/​s00774-005-0660-1 CrossRefPubMed
Metadaten
Titel
A 2-year prospective densitometric study on the influence of Fok-I gene polymorphism in young patients with thalassaemia major
verfasst von
M. Dimitriadou
A. Christoforidis
L. Fidani
M. Economou
E. Vlachaki
M. Athanassiou-Metaxa
G. Katzos
Publikationsdatum
01.02.2016
Verlag
Springer London
Erschienen in
Osteoporosis International / Ausgabe 2/2016
Print ISSN: 0937-941X
Elektronische ISSN: 1433-2965
DOI
https://doi.org/10.1007/s00198-015-3264-1

Weitere Artikel der Ausgabe 2/2016

Osteoporosis International 2/2016 Zur Ausgabe

Arthropedia

Grundlagenwissen der Arthroskopie und Gelenkchirurgie. Erweitert durch Fallbeispiele, Videos und Abbildungen. 
» Jetzt entdecken

Update Orthopädie und Unfallchirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.